abnobaVISCUM Fraxini
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for abnobaVISCUM Fraxini, covering 2015-05-06 to 2015-05-06. Get the full timeline:
Most recent: Clinical Trial Update: Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer [Phase 1, Phase 2]